IDEXX Cancer Dx testing
A revolutionary new cancer panel for dogs that detects lymphoma earlier than ever is now available.¹
Find cancer early.
So you can fight it early.
- Detect and specifically identify lymphoma with a simple blood specimen.¹
- Can be affordably and easily incorporated into testing for sick pets and IDEXX Preventive Care profiles for at-risk dogs.†
- Actionable next-step guidance from world-class oncologists.
- According to early data, IDEXX Cancer Dx testing can detect lymphoma before clinical signs are present.¹
A new recruit in the war against cancer.
Cancer is a leading cause of death in canines, with 1 in 4 dogs in the U.S. expected to be diagnosed with cancer in their lifetime.² 73% of pet owners are interested in having a cancer screening test for their pet—and now you can offer them one.³
The revolutionary technology behind IDEXX Cancer Dx testing detects a proprietary, circulating biomarker specific to canine lymphoma, accurately detecting lymphoma in at-risk dogs.†¹
Early. Accurate. The first of its kind.
With 79% sensitivity and 99% specificity rates,¹ IDEXX Cancer Dx testing demonstrates performance that is comparable to, if not superior to, the current standards widely and consistently used in human cancer screening diagnostics today.⁴ IDEXX Cancer Dx testing also provides a lymphoma-specific result with additional characterization in a portion of cases at no additional cost.
In many cases, B-cell vs. T-cell phenotype classification will be provided with positive results at no additional cost.
Detecting lymphoma earlier is just the beginning.
IDEXX Cancer Dx testing accurately and specifically detects lymphoma. And that’s just the beginning. In the coming years, we plan to add detection of more of the most common canine cancers. IDEXX Cancer Dx testing fits seamlessly into your IDEXX Preventive Care profiles and sick-patient testing protocols.
We added deeper insights to your preventive care offering.
Cancer Dx testing is now available to add to your preventive care diagnostics for at-risk dogs.† IDEXX Preventive Care helps you tailor recommendations for every patient's needs. It's a comprehensive solution that includes a team of experts and powerful tools to spot trends and interpret patient results.
Before you can fight lymphoma, you have to find it.
We recommend screening at-risk dogs, including all dogs aged 7 years or older and dogs of high-risk breeds—especially the breeds listed below—aged 4 or older.
| Beagle Bernese mountain dog Boxer Bullmastiff Doberman pinscher English bulldog Flat-coated retriever |
French bulldog Golden retriever Labrador retriever Miniature schnauzer Rottweiler Scottish terrier |
Put our cancer portfolio to work.
We've developed a full suite of diagnostic tools for treatment, monitoring, management, and support for every stage of veterinary oncology.
Support
Resources
Access IDEXX Cancer Dx testing resources, including diagnostic updates, white papers, guides, blog articles, links to webinars and courses, and more.
Directory of Tests and Services
Browse the online Directory of Tests and Services to see a comprehensive list of offerings from IDEXX Reference Laboratories.
Medical consultants
Direct live access and personalized guidance from our team of IDEXX experts, including our Diagnostic Support Technicians, Diagnostic Support Veterinarians, and board-certified veterinary specialists.
†At-risk dogs include all dogs ≥ 7 years old and high-risk breeds ≥ 4 years old.
References
- Data on file at IDEXX Laboratories, Inc. Westbrook, Maine USA: Data based on testing performed at IDEXX Reference Laboratories in North America between November 1, 2024, and December 6, 2024. Analysis Report: IDEXX Cancer Dx Validation, 100282 [008_CancerDx-Validation-Report-2.Rmd].
- What are the most common types of cancers in dogs? How many dogs typically get cancer? Veterinary Cancer Society; 2021. Accessed March 13, 2025. www.vetcancersociety.org/pet-owners/faqs
- Data on file at IDEXX Laboratories, Inc. Westbrook, Maine USA: IDEXX quantitative research with dog owners, May 2024 (n = 480).
- Pisano ED, Hendrick RE, Yaffe MJ, et al. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology. 2008;246(2):376–383. doi:10.1148/radiol.2461070200